Stem Cell Therapy for ALS in Istanbul, Turkey

The route is the largest single factor, because an intrathecal procedure involves procedure-room time, imaging and a recovery period that an infusion does not. Your written quote itemizes the neurology review, the number of sessions, respiratory monitoring, mobility assistance and accompanying-caregiver arrangements separately, and states what it excludes.

Both intravenous infusion and intrathecal administration are used in ALS research, and they are not interchangeable. Our medical team selects the route from your respiratory status, spinal anatomy, medication, bleeding risk and how much time you can spend in the procedure room, then sets out the reasoning and the specific risks in your plan.

Advanced disease changes the assessment rather than ending it. Breathing capacity, swallowing safety, pressure-injury risk, seating and transfer needs and overall stability all decide whether a trip to Istanbul is reasonable. Where travel would cost more than it could return, our team says so and suggests continuing care closer to home.

Before you fly home we agree the measures that will be tracked - function, breathing, speech, weight and the daily tasks that matter to you - and when they will be reviewed. Follow-up continues remotely with our medical team and can be shared with your neurologist so the two plans stay aligned.

Yes. Our regenerative medicine program works with mesenchymal stromal cells (MSCs) grown from Wharton's jelly, the gelatinous tissue inside the umbilical cord. It is donated after a healthy birth with written maternal consent, from tissue that would otherwise be discarded, so nothing is taken from mother or baby and none of the ethical questions attached to embryonic sources arise. Because these cells expand readily in culture, a batch is characterised and release-tested before it reaches anyone. Your written plan names the material, how it is prepared, the dose, the route of administration and the schedule, and our medical team explains why each of those was chosen for your case.

Wharton's jelly is a young, perinatal tissue rather than an adult one, so the starting material does not carry the age or the health history of the person being treated, and nothing has to be harvested from you on the day. These cells also have a low-immunogenicity profile, which is why this source is studied for use between unrelated people. Most of all, they are strong secretors: the signalling molecules MSCs release are the mechanism most current research centres on, and that is what a plan is built around.

The length of stay follows your plan: the route of administration, the number of sessions, the monitoring after each one, and any mobility or assistance you need. Our patient coordination team confirms appointment dates, daily timings and the expected length of the visit in writing before you book flights.

No medical procedure is free of risk. Our medical team screens for infection, bleeding risk, medication interactions and other contraindications before treatment, explains the risks specific to the route used in your plan, and monitors you during administration and afterwards. If something makes treatment unsafe for you, we say so instead of proceeding.

Goals are set with you and described as aims, not results. Regenerative medicine treatments are planned individually, responses vary between patients and no clinical outcome can be guaranteed. Your plan states what will be measured, when it will be reviewed, and how treatment sits alongside the care you already receive.

Send your confirmed diagnosis, recent reports and imaging, your current medication list, previous procedures and the goals that matter to you. Our medical team reviews them remotely and comes back with an assessment of whether treatment in Istanbul is appropriate for your case, and what the next step would be.